Finch Therapeutics Group Inc (FNCH)

OTC Markets
Currency in USD
12.750
0.000(0.00%)
Closed·
FNCH Scorecard
Full Analysis
High shareholder yield
FNCH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.55012.750
52 wk Range
1.27015.850
Key Statistics
Edit
Prev. Close
12.75
Open
12.66
Day's Range
12.55-12.75
52 wk Range
1.27-15.85
Volume
2.54K
Average Volume (3m)
2.13K
1-Year Change
791.61%
Book Value / Share
8.85
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FNCH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Finch Therapeutics Group Company Profile

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn’s disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts.

Compare FNCH to Peers and Sector

Metrics to compare
FNCH
Peers
Sector
Relationship
P/E Ratio
−1.5x−0.4x−0.5x
PEG Ratio
−0.020.010.00
Price/Book
1.5x1.8x2.6x
Price / LTM Sales
-9.7x3.2x
Upside (Analyst Target)
-104.0%46.0%
Fair Value Upside
Unlock17.4%6.3%Unlock

Earnings

Latest Release
Aug 13, 2024
EPS / Forecast
-3.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FNCH Income Statement

FAQ

What Is the Finch Therapeutics Group (FNCH) Stock Price Today?

The Finch Therapeutics Group stock price today is 12.75.

What Stock Exchange Does Finch Therapeutics Group Trade On?

Finch Therapeutics Group is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Finch Therapeutics Group?

The stock symbol for Finch Therapeutics Group is "FNCH."

What Is the Finch Therapeutics Group Market Cap?

As of today, Finch Therapeutics Group market cap is 20.47M.

What Is Finch Therapeutics Group's Earnings Per Share (TTM)?

The Finch Therapeutics Group EPS (TTM) is -8.82.

From a Technical Analysis Perspective, Is FNCH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Finch Therapeutics Group Stock Split?

Finch Therapeutics Group has split 1 times.

How Many Employees Does Finch Therapeutics Group Have?

Finch Therapeutics Group has 1 employees.

What is the current trading status of Finch Therapeutics Group (FNCH)?

As of 14 Jul 2025, Finch Therapeutics Group (FNCH) is trading at a price of 12.75, with a previous close of 12.75. The stock has fluctuated within a day range of 12.55 to 12.75, while its 52-week range spans from 1.27 to 15.85.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.